The Three Rs for Preventing Heart Failure Readmission: Review, Reassess, and Reeducate (vol 39, pg 85, 2019)

被引：0

作者：

Ryan

机构：

来源：

CRITICAL CARE NURSE | 2019年 / 39卷 / 05期

关键词：

D O I：

10.4037/ccn2019656

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

收藏

页码：12 / 12

页数：1

相关论文

共 50 条

[41] Canadian Cardiovascular Society-Canadian Heart Failure Society Focused Clinical Practice Update of Patients With Differing Heart Failure Phenotypes (vol 39, pg 1030, 2023)
Mielniczuk, Lisa
Ezekowitz, Justin A.
Howlett, Jonathan G.
Leong, Derek
CANADIAN JOURNAL OF CARDIOLOGY, 2023, 39 (11)
[42] Oral propranolol in prevention of severe retinopathy of prematurity: a systematic review and meta-analysis (vol 39, pg 1584, 2019)
Stritzke, A.
Kabra, N.
Kaur, S.
Robertson, H. L.
Lodha, A.
JOURNAL OF PERINATOLOGY, 2019, 39 (12) : 1695 - 1695
[43] CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications (vol 39, pg 445, 2019)
Dodick, D. W.
CEPHALALGIA, 2019, 39 (08) : 1069 - 1069
[44] An Intervention to Improve Physical Function and Caregiver Perceptions in Family Caregivers of Persons With Heart Failure (vol 39, pg 181, 2018)
Gary, R.
Dunbar, S. B.
Higgins, M.
Butts, B.
Corwin, E.
Hepburn, K.
Miller, A. H.
JOURNAL OF APPLIED GERONTOLOGY, 2020, 39 (02) : I - I
[45] Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America (vol 140, pg e294, 2019)
Dunlay
CIRCULATION, 2019, 140 (12) : E692 - E692
[46] Moderators of Response to Cognitive Behavior Therapy for Major Depression in Patients With Heart Failure (vol 81, pg 506, 2019)
Smagula, S. F.
Freedland, K. E.
Steinmeyer, B. C.
Wallace, M. J.
Carney, R. M.
Rich, M. W.
PSYCHOSOMATIC MEDICINE, 2019, 81 (07): : 674 - 674
[47] Global burden of heart failure: a comprehensive and updated review of epidemiology (vol 118, pg 3272, 2022)
不详
CARDIOVASCULAR RESEARCH, 2023, 119 (06) : 1453 - 1453
[48] Systematic review: cardiac resynchronization in patients with symptomatic heart failure (vol 141, pg 381, 2004)
McAlister, FA
Ezekowitz, JA
Wiebe, N
Rowe, B
Spooner, C
Crumley, E
ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) : 311 - 311
[49] Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure (vol 74, pg 2893, 2019)
Kotecha, D.
Gill, S. K.
Flather, M. D.
Holmes, J.
Packer, M.
Rosano, G.
Bohm, M.
McMurray, J. J., V
Wikstrand, J.
Anker, S. D.
van Veldhuisen, D. J.
Manzano, L.
von Lueder, T. G.
Rigby, A. S.
Andersson, B.
Kjekshus, J.
Wedel, H.
Ruschitzka, F.
Cleland, J. G. F.
Damman, K.
Redon, J.
Coats, A. J. S.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (13) : 1615 - 1615
[50] Dapaglifozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction (vol 21, pg 701, 2021)
Blair, Hannah A.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (01) : 109 - 109

← 1 2 3 4 5 →